These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 19650762

  • 1. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
    Pasquali R, Gambineri A.
    Expert Opin Ther Targets; 2009 Oct; 13(10):1205-26. PubMed ID: 19650762
    [Abstract] [Full Text] [Related]

  • 2. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
    Dhindsa G, Bhatia R, Dhindsa M, Bhatia V.
    J Postgrad Med; 2004 Oct; 50(2):140-4. PubMed ID: 15235215
    [Abstract] [Full Text] [Related]

  • 3. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA, Hernández Marín I, Ayala AR.
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [Abstract] [Full Text] [Related]

  • 4. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Checa MA, Requena A, Salvador C, Tur R, Callejo J, Espinós JJ, Fábregues F, Herrero J, Reproductive Endocrinology Interest Group of the Spanish Society of Fertility.
    Hum Reprod Update; 2005 Jun; 11(4):375-90. PubMed ID: 15878899
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 11. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST, Nestler JE.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E, Kiapekou E, Loutradis D.
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [Abstract] [Full Text] [Related]

  • 14. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of insulin sensitizers in polycystic ovarian syndrome.
    Baillargeon JP.
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1012-22. PubMed ID: 16259222
    [Abstract] [Full Text] [Related]

  • 18. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK, Ehrmann DA.
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovary syndrome in adolescence--a therapeutic conundrum.
    Homburg R, Lambalk CB.
    Hum Reprod; 2004 May; 19(5):1039-42. PubMed ID: 15016769
    [Abstract] [Full Text] [Related]

  • 20. Drug treatments for polycystic ovary syndrome.
    Radosh L.
    Am Fam Physician; 2009 Apr 15; 79(8):671-6. PubMed ID: 19405411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.